We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Should You Buy, Hold or Sell VRNO Stock Post Q3 Earnings Release?
Read MoreHide Full Article
Key Takeaways
Verano posted a Q3 loss of 12 cents and a 6% sales drop to $203 million.
Gross margin fell 300 basis points to 47% as U.S. pricing pressure persisted.
SG&A costs fell 13% as Verano focused on efficiency, expansion and innovation.
Last week, Verano Holdings Corporation (VRNO - Free Report) reported its third-quarter 2025 results. While earnings missed our estimates, sales met the mark.
The U.S.-based cannabis operator posted a wider-than-expected loss of 12 cents, in line with the year-ago quarter. Sales declined 6% year over year to about $203 million, primarily reflecting price compression and intensified competition across key markets.
However, long-term investors typically focus beyond a single quarter’s numbers and assess broader fundamentals. Let’s explore the company’s fundamentals to better understand how to play the stock after its latest results.
Domestic Headwinds Deter Verano’s Sales Growth
Despite being regarded as one of the largest cannabis operators in terms of geographic scope, Verano faces revenue pressure from a challenged domestic environment. As the company derives all of its revenues from the U.S. market, persistent price compression, competitive intensity and uneven regulatory progress have weighed on top-line performance.
During the third quarter, retail sales were essentially flat year over year at $164 million, reflecting seasonal softness in Florida and Arizona as well as heightened pricing competition in Illinois and New Jersey. Meanwhile, wholesale revenues declined 9% year over year to $82 million, as broader industry pricing pressures continued to affect sell-through and inventory dynamics across key markets.
Margin performance also reflected these market conditions. Gross margin contracted approximately 300 basis points to 47%, driven by promotional activity and retail price adjustments. However, Verano’s disciplined focus on operating efficiency supported cost performance. Selling, general, and administrative (SG&A) expenses declined 13% year over year to $80.6 million, underscoring ongoing optimization efforts even amid store expansion and product launches.
Despite the headwinds, Verano maintained an optimistic tone for Q4 and beyond. This was backed by the company’s continued emphasis on operational efficiencies, retail expansion and product innovation (including a new vape system) as foundational to longer-term momentum. As part of its long-term positioning, Verano recently completed its redomicile from British Columbia to Nevada, aligning its corporate structure with its U.S.-based operations. It believes that this move will enhance its acceptance in U.S. capital markets and also improve the marketability of its shares.
Cutthroat Competition in the Cannabis Space
Verano competes in an overcrowded market, against the likes of Canopy Growth (CGC - Free Report) , Green Thumb Industries (GTBIF - Free Report) and Tilray Brands (TLRY - Free Report) , which are also pursuing similar expansion and cost-cutting strategies.
Companies like Canopy and Tilray are also expanding their footprints beyond geographic borders, in markets like Europe and Australia. This international exposure gives them an edge over Verano and Green Thumb, which remain fully dependent on an increasingly saturated and fragmented U.S. market.
VRNO Stock Performance and Estimates
Shares of Verano have underperformed the industry this year so far, as shown in the chart below.
Image Source: Zacks Investment Research
Loss estimates for 2025 and 2026 have widened over the past 30 days.
Image Source: Zacks Investment Research
How to Play VRNO Stock?
Although Verano’s efforts to streamline its cost base and dispensary growth are beginning to reflect in its fundamentals, domestic pricing pressure and stiff competition remain near-term challenges. President Trump’s recent comments on marijuana rescheduling have reignited optimism in the cannabis sector, but investors may prefer to wait for clearer signs before initiating or expanding positions.
VRNO currently has a Zacks Rank #4 (Sell), which suggests that the stock looks vulnerable to volatility and may carry elevated risk for conservative investors.
Image: Bigstock
Should You Buy, Hold or Sell VRNO Stock Post Q3 Earnings Release?
Key Takeaways
Last week, Verano Holdings Corporation (VRNO - Free Report) reported its third-quarter 2025 results. While earnings missed our estimates, sales met the mark.
The U.S.-based cannabis operator posted a wider-than-expected loss of 12 cents, in line with the year-ago quarter. Sales declined 6% year over year to about $203 million, primarily reflecting price compression and intensified competition across key markets.
However, long-term investors typically focus beyond a single quarter’s numbers and assess broader fundamentals. Let’s explore the company’s fundamentals to better understand how to play the stock after its latest results.
Domestic Headwinds Deter Verano’s Sales Growth
Despite being regarded as one of the largest cannabis operators in terms of geographic scope, Verano faces revenue pressure from a challenged domestic environment. As the company derives all of its revenues from the U.S. market, persistent price compression, competitive intensity and uneven regulatory progress have weighed on top-line performance.
During the third quarter, retail sales were essentially flat year over year at $164 million, reflecting seasonal softness in Florida and Arizona as well as heightened pricing competition in Illinois and New Jersey. Meanwhile, wholesale revenues declined 9% year over year to $82 million, as broader industry pricing pressures continued to affect sell-through and inventory dynamics across key markets.
Margin performance also reflected these market conditions. Gross margin contracted approximately 300 basis points to 47%, driven by promotional activity and retail price adjustments. However, Verano’s disciplined focus on operating efficiency supported cost performance. Selling, general, and administrative (SG&A) expenses declined 13% year over year to $80.6 million, underscoring ongoing optimization efforts even amid store expansion and product launches.
Despite the headwinds, Verano maintained an optimistic tone for Q4 and beyond. This was backed by the company’s continued emphasis on operational efficiencies, retail expansion and product innovation (including a new vape system) as foundational to longer-term momentum. As part of its long-term positioning, Verano recently completed its redomicile from British Columbia to Nevada, aligning its corporate structure with its U.S.-based operations. It believes that this move will enhance its acceptance in U.S. capital markets and also improve the marketability of its shares.
Cutthroat Competition in the Cannabis Space
Verano competes in an overcrowded market, against the likes of Canopy Growth (CGC - Free Report) , Green Thumb Industries (GTBIF - Free Report) and Tilray Brands (TLRY - Free Report) , which are also pursuing similar expansion and cost-cutting strategies.
Companies like Canopy and Tilray are also expanding their footprints beyond geographic borders, in markets like Europe and Australia. This international exposure gives them an edge over Verano and Green Thumb, which remain fully dependent on an increasingly saturated and fragmented U.S. market.
VRNO Stock Performance and Estimates
Shares of Verano have underperformed the industry this year so far, as shown in the chart below.
Image Source: Zacks Investment Research
Loss estimates for 2025 and 2026 have widened over the past 30 days.
Image Source: Zacks Investment Research
How to Play VRNO Stock?
Although Verano’s efforts to streamline its cost base and dispensary growth are beginning to reflect in its fundamentals, domestic pricing pressure and stiff competition remain near-term challenges. President Trump’s recent comments on marijuana rescheduling have reignited optimism in the cannabis sector, but investors may prefer to wait for clearer signs before initiating or expanding positions.
VRNO currently has a Zacks Rank #4 (Sell), which suggests that the stock looks vulnerable to volatility and may carry elevated risk for conservative investors.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.